Skip to main content

Peer Review reports

From: CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer

Original Submission
11 Jun 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
10 Oct 2015 Editorially accepted
16 Oct 2015 Article published 10.1186/s12885-015-1776-x

You can find further information about peer review here.

Back to article page